.gif)
Researchers in Lund have discovered an antitoxin mechanism that seems to be able to neutralise hundreds of different toxins and may protect bacteria against virus attacks. The mechanism has been named Panacea, after the Greek goddess of medicine whose name has become synonymous with universal cure. The understanding of bacterial toxin and antitoxin mechanisms will be crucial for the future success of so-called phage therapy for the treatment of antibiotic resistance infections, the researchers say. The study has been published in PNAS.
So-called toxin-antitoxin systems, a kind of on-off switch in many bacterial DNA genomes, are increasingly being found to defend bacteria against attack by bacteriophages - viruses that infect bacteria. Activation of toxins allows bacterial populations to go into a kind of lockdown that limits growth and therefore the spread of the virus. As such, understanding the diversity, mechanisms and evolution of these systems is critical for the eventual success of phage therapy to treat antibiotic resistance infections.
Toxin-antitoxin pairs consist of a gene encoding a toxin that dramatically inhibits bacterial growth and an adjacent gene encoding an antitoxin that counteracts the toxic effect. It is like keeping a bottle of poison on a shelf next to a bottle of the antidote. While toxin-antitoxin pairs have been seen to evolve to associate with new toxins or antitoxins before, the scale of the neutralisation ability seen with Panacea - so called hyperpromiscuity - is unprecedented, explains researcher and group leader Gemma Atkinson at Lund University, who has led the study
PhD student and co-first author Chayan Kumar Saha made a computer program for analysing the kinds of genes that are found next to each other in bacterial genomes. The team then used this tool to predict new antitoxin genes found next to some very potent toxins that they have previously worked on.
We were startled by the discovery that one particular antitoxin protein fold can be found in toxin-antitoxin-like arrangements with dozens of different kinds of toxins. Many of these toxins are new to science.
The other first author Tatsuaki Kurata, Lund University, has confirmed experimentally that several of these systems are genuine toxins neutralized by the neighbouring antitoxin genes. The study shows that what we know so far about the diversity of toxin-antitoxin systems probably is just the tip of the iceberg, and that there could be a range of similar systems that have gone under the radar until now.
As well as being important for understanding the weird and wonderful world of bacterial biochemistry, the discovery of new toxin-antitoxin systems is important for so-called phage therapy against antibiotic resistant infections. As bacteria have increasingly become resistant to antibiotics, other approaches are needed for eliminating infections, says Gemma Atkinson.
The principle of phage therapy is to treat patients with cocktails of bacteriophages – viruses that infect bacteria – in order to kill the bacteria causing infection. However bacteria carry various defence systems to protect themselves from phages, and this includes toxin-antitoxin systems.
Thus identifying toxin-antitoxin systems of pathogens may help us in the future design phage therapy that can counter this layer of defence, explains Gemma Atkinson.
